Roche's EvrysdiÂ® (risdiplam) - the first and only oral treatment for adults and children two months or older suffering from Spinal Muscular Atrophy (SMA) - now available in India
- This disease-modifying therapy is the first and only approved treatment available in India for SMA patients across all types.
- Evrysdi ® is being studied as part of the broadest and largest global clinical trial program in SMA - from newborn infants to adults aged 60 years, with varying symptoms and motor function.
MUMBAI, India, July 29, 2021 /PRNewswire/ -- Roche today announced the launch of Evrysdi ® (risdiplam), the first and only approved treatment in India for Spinal Muscular Atrophy (SMA) patients. Evrysdi ® was first approved by the US FDA in August 2020 and is today available in India within 11 months of the US approval. Since its launch, over 4,000 SMA patients across 50+ countries have benefitted from Evrysdi ®.
SMA is a severe, progressive rare neuromuscular disease that can be fatal. It affects approximately one in 10,000 live births globally1 and one in 7,744 live births in India2 and is the leading genetic cause of infant mortality. SMA is caused by a mutation of the survival motor neuron 1 (SMN1) gene, which leads to a deficiency of SMN protein. This protein is found throughout the body and is essential to the function of nerves that control muscles and movement. Without it, nerve cells cannot function correctly, leading to muscle weakness over time. Depending on the type of SMA, an individual's physical strength and their ability to walk, eat or breathe can be significantly diminished or lost.
About Evrysdi ® and global clinical trials
Evrysdi ® is administered daily at home orally (it is supplied as powder which is constituted into a liquid solution and taken once daily by mouth or feeding tube if required) and is designed to treat SMA by increasing production of the Survival Motor Neuron (SMN) protein. It is approved for the treatment of spinal muscular atrophy (SMA) in adults and children 2 months of age and older.
Evrysdi ® is being studied in more than 450 people as part of the broadest, large and robust clinical trial program in SMA. The program included newborn infants to adults aged 60 years with varying symptoms and motor function, and is the only program that has included those that were previously treated for SMA with another medication.
Evrysdi ® was approved by Indian Health Authorities after reviewing its efficacy and safety data from three global clinical studies designed to represent a broad spectrum of people living with SMA:
- FIREFISH3 in symptomatic infants aged 1 to 7 months with Type 1 SMA
- SUNFISH3 in children and adults aged 2 to 25 years. SUNFISH is the first and only placebo-controlled trial to include adults with Types 2 and 3 SMA.
Evrysdi ® showed clinically meaningful improvements in motor function across these two clinical trials in people with varying ages and levels of disease severity, including Types 1, 2, and 3 SMA. Infants achieved the ability to sit without support for at least 5 seconds, a key motor milestone not normally seen in the natural course of the disease. Evrysdi ® also improved survival without permanent ventilation at 12 and 23 months, compared to natural history. Evrysdi maintained the ability to swallow and feed orally in the majority of the infants after 2 years of therapy. This is a unique characteristic of Evrysdi that was not observed with other medications for SMA.
3. JEWELFISH3 (interim data) is a study assessing people with any SMA type and disease severity who have previously been treated with other SMA targeted therapies between 6 months and 60 years. This study enrolled the broadest patient population ever studied in an SMA trial. Data from the JEWELFISH study, which included a diverse patient population with a high degree of motor impairment, show that Evrysdi ® has a favorable safety profile in patients previously treated with other SMA targeting therapies. Evrysdi also showed to improve SMN protein levels to 2 fold and above in all the patients who have received a previous therapy.
Evrysdi's clinical development program also includes:
RAINBOWFISH3 is a study assessing pre-symptomatic infants with Type 1 SMA from birth to 6 weeks old. Preliminary efficacy data from RAINBOWFISH showed that infants treated for 12 months achieved age appropriate motor milestones within the WHO windows for healthy children, including sitting, standing and walking, and improvements in motor function.
V Simpson Emmanuel, CEO and Managing Director, Roche Pharma India, says, "The launch of Evrysdi ® in India is a fine example of Roche living its purpose of 'Doing now what patients need next'. We are betting big on solving complex challenges related to rare diseases as we believe no patient should be deprived an opportunity to live a healthy life, however complex or rare the disease is. Today heralds a new journey of hope as we are all coming together to add color into the lives of SMA patients in India with the launch of Evrysdi ®, the first and only approved treatment in India for patients living with SMA. This also marks our foray into rare disease treatment in India."
Patient Support Program (PSP) to drive access
To ensure every patient gets access to this disease modifying therapy, Roche is announcing its Patient Support program (PSP) for Evrysdi ®. Through this program:
- In the first two years of treatment, Roche provides three bottles free for every two bottles bought by the patient
- From the third year onwards, Roche provides two bottles free for every one bottle bought by the patient
To provide a holistic solution to SMA patients and caregivers, Roche identified the most important challenges they face throughout their journey and have designed solutions to support them to mitigate those challenges. Through the PSP program, Roche will provide services like: Physiotherapy, Financial counselling, Psychosocial and Nutritional counselling to SMA patients. Patients and caregivers can reach out to us at 1800-202-4755 for information on the PSP program.
Home delivery of Evrysdi ®: SMA patients have weak pulmonary health and find it difficult to visit a hospital to receive therapy, especially in COVID times. Moreover, motor disability adds to this burden and makes it very difficult for these patients and caregivers to travel to receive the drug. To solve this challenge, Roche will provide free home delivery of Evrysdi ® to each and every patient following consent from the patient/ caregiver and their HCPs. Being the only oral medication for SMA that can be administered in a home setting, this facility will add tremendous convenience to both patients and their caregivers, especially the added challenge COVID-19 poses. Patients, caregivers and HCPs can reach out to us at 1800-202-4755 to know more about Evrysdi's availability and free home delivery.
"Given the majority of people with SMA in India remain untreated, we believe Evrysdi, with its highly efficacious clinical profile and oral administration advantage, will offer meaningful benefits for many living with this rare neurological disease," said Dr. Bruno Jolain, Chief Medical Officer, Roche Pharma India. "Administration of Evrysdi requires no hospitalization, no anesthesia, no specialized care center, no complex administration and no steroids. A simple oral administration gives SMA patients, treating physicians and caregivers more control over their daily lives."
"Throughout their lives, many people with SMA may lose their ability to perform critical movements, which can impact the ability to independently participate in different aspects of daily life and even be life altering. SMA patients in India have long lived without a viable treatment option. We are today encouraged by the availability of an approved solution in India," said Alpana Sharma, Co-Founder & Director Patient Advocacy at CureSMA Foundation of India.
"The launch of Evrysdi in India is an eagerly awaited milestone for our community. We appreciate Roche's commitment in making this drug available in India soon after its global launch and in developing a treatment that can be administered at home," said Archana Vashist Panda, Co-Founder & Director Patient Advocacy, CureSMA Foundation of India.
3Additional details regarding the clinical trials are available in the annexure: Evrysdi: Summary of Key Facts
About Roche Products (India) Pvt. Ltd.
Roche Products (India) Private Limited was incorporated in 1994 as a wholly owned subsidiary of the Roche Group, headquartered in Basel, Switzerland. Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. For more than 60 years, Roche has been committed to making a difference to the lives of people in India. Today, Roche is the leader in oncology treatment in India; apart from cancer, Roche's has innovative medicines in other therapy areas too: transplantation, rheumatoid arthritis (RA), and chronic kidney disease (CKD)-related anaemia. Roche believes in making the latest and most innovative medicines accessible to patients in India in the fastest possible time. For more than 50 years, Roche has been developing medicines with the goal to redefine treatment in oncology. Today, Roche is investing more than ever in our effort to bring innovative treatment options that help a person's own immune system fight cancer. For more information on Roche Pharma India, visit www.rocheindia.com.
More News by PR Newswire India
Nils Andersen-RĂ¶ed joins Binance from Europol to further strengthen investigations and audit team
Asian Hall of Fame Unveils New Inductees
PharmaZell and Novasep enter into exclusive negotiations in new drive to create a technology-driven leader for complex small molecules and ADCs of global scale
KĂ¶rber recognized by GartnerÂ® in 2021 Critical Capabilities for Warehouse Management Systems Report
Designing the Digital Future at Porsche with Executives Mattias Ulbrich and Dr. Oliver Seifert Top Highlight at the 2021 Global SAFeÂ® Summit
Chengdu Motor Show Witnesses Debut of New Models of GWM POER, With Sales of 200,000 Units Since Its Launch
Satisfai Health acquires global license for AI software to detect early cancer in Barrett's Esophagus
SC Johnson and Liverpool Football Club Team Up to Tackle Plastic Waste; Anfield Plastic to Become New Mr MuscleÂ® Bottles
The GIGABYTE Complete Gaming Monitor Lineup Received High Praise for Stellar Performance
Syapse Awarded 2021 Technology Innovation Leadership Award by Frost & Sullivan for Accelerating Real-world Care Delivery
Validic Empowers Physicians and Care Managers to Manage Personal Health Data at Scale
CRW Consulting & Distribution, LLC Announces Nathan PochĂ© as President and Managing Partner
Tom Golisano Gifts $30 Million to Special Olympics to Expand Critical Health Services Globally for People with Intellectual Disabilities
CRW Consulting & Distribution, LLC Announces Jeremi Day as Chief Technical Officer and Managing Partner
Ambience Malls to Celebrate Celebratory Season with Festive Fervor
Altair Future.Industry Experience Explores What's Next in Advanced Manufacturing
Hisense Laser TV Seeing Explosive Growth, Global Sales of Laser TVs Surge Over 600% YoY from January to August 2021
CGTN: China's fervor for sports continues with opening of 'mini Olympics'
DG Financial Technology, Japan acquires majority stake in Pune-based Vizitech Solutions
Freight trains from Chengdu's Qingbaijiang boost global trade
Grasim Industries lays the foundation stone for Aditya Birla Public School at Pallipalayam, Tamil Nadu, a major weaving and spinning hub
Arctech Launches World's First PV Company-owned Wind Tunnel Laboratory to Smartly Increase the Stability of Trackers
LabodĂ©t Releases a Luxury Leather MagSafe Compatible Collection for iPhone 13 Series
Rockwell Automation: Strengthening supply-chain resilience amid VUCA
COYO and Smarp join forces to form a global Top 5 software provider in the employee communications and engagement space
Getac Focuses on the Entire Logistics Chain and Launches a Virtual Exhibition to Present Rugged Solutions for Transport and Logistics.
Dataiku Recognized as a 2021 GartnerÂ® Peer Insights Customers' Choice for Data Science and Machine Learning Platforms
Euroclear completes acquisition of MFEX Group
Unveiling Right Issue, BRI to Build the Largest Ultra-Micro Ecosystem in Indonesia
Purple Quarter Facilitates the Appointment of Amit Saxena as the CTO for RBI Innovation Hub
UST is now certified as a CarbonNeutralÂ® Company
PR Newswire's 2021 Healthcare Media Pitching Kit (APAC Edition) Reveals News and Trends Journalists Seek from Brands
Her Majesty Queen Noor of Jordan and other members of the Scotia Group declare "diplomatic emergency" and call on COP 26 summit to deliver rapid, permanent emissions reductions to avoid a "climate tragedy"
Allianz Partners expands its Digital Health Assistant to ten markets in Asia-Pacific
Awareness on Obesity and Diabetes through Digital Platform to Be Implemented In Maharashtra with the Help Of State Government
Meek Mill Announces Plans to Release Long-Awaited, Fifth Studio Album "Expensive Pain" on October 1
CGTN: China calls for innovation to promote high-quality development in Shaanxi
Plug and Play to collaborate on innovation in Artificial Intelligence with INTEMA by MTS AI
Design District, A New Permanent Home For The Creative Industries Opens On Greenwich Peninsula, London
Charles Bodner Joins CSafe Global as Chief Financial Officer
130th Canton Fair to Bring an Extensive 5-day Integrated Exhibition from Oct 15 to 19
De Tomaso Welcomes Carmen Jorda
Vectorworks, Inc. Launches 2022 Version of BIM and CAD Product Line
ArisGlobal Announces Leading Speakers for Breakthrough2021 Conference
Park Place Technologies Acquires the Hardware Maintenance and Data Migration Assets from Congruity360
Onyx Acclaimed by Frost & Sullivan for Facilitating Health Data Interoperability with Its SAFHIR Platform
World Trade Centers Association Stresses Rise of Digital Globalization in Trade at 2021 CIFTIS and CIFIT, Two Leading International Conferences in Trade and Investment in China
Blume Global Announces New Investment by Bridgepoint
Within3 Reimagines Life Science Communications to Address Insight Gaps with Industry-first, Holistic Platform
Sasol, Haldor TopsĂ¸e expand G2LTM licensing collaboration to grow sustainable synthetic fuels and chemicals globally
Cyient expands its Digital Solutions portfolio for the Aerospace industry with PPAP4Aero
Top Organizations Honored with Frost & Sullivan Asia-Pacific Best Practices Awards
AWE2022 Announces to Be Held in Shanghai, China in Next March
Cookpad's Jio Phone app puts daily recipe inspiration into the hands of 100M+ people across India
Timex Group And Judith Leiber Couture Announce Collaboration And New Partnership
CRW Consulting & Distribution appoints Blast Abrasives Supply as Southeast Asia Distributor of Corr-Zeâ„˘ Products
TOUCHBeauty REVIVE Defines New Generation of Beauty Devices Focused on Technological Innovation and Powerful Results
ThinkSono DVT detection software results are published in Nature digital medicine (npj)
Infosys and SAP Collaborate to Provide Business Process Transformation-as-a-Service to Enterprises
CCTV+: Exhibition hall serves as important carrier of intangible cultural heritage in China's Shaanxi Province
FTC Solar's New Voyager+ Solar Tracker for Large Format Modules Withstands Winds up to 120 Miles Per Hour
Fragomen Launches Global Hybrid Working Model
Odessa announces investment from Thomas H. Lee Partners to accelerate growth
50 Best Awards London's Ikoyi Restaurant As The American Express One To Watch 2021
GWM Debuts Its New Coupe SUV - HAVAL H6S with Many Highlights
Easiloan, an AI-enabled fintech platform for home loans, raises INR 80 million from Tomorrow Capital
Sputnik V Demonstrates 97.2% Efficacy And High Safety Profile Against COVID During The Vaccination Campaign In Belarus
WorkForce Software and Pandora to Discuss How HR Can Revolutionise Every Employee's Experience at the Virtual Gartner ReimagineHR Conference
Students challenged to pull 100-ton Volvo hauler using only LEGO bricks
2021 Centre for Medicines Research (CMR) Pharmaceutical R&D Factbook from Clarivate Finds Drug Approvals at a 10-year High Despite the Challenges of COVID-19
Zalando celebrates one year of 'Drama-free' pre-owned fashion with a dedicated campaign to launch iconic celebrity styles.
Financial Service Companies Look to Elevate Security by Partnering with Cloud Experts Offering Integrated Solutions
Tycoons Group, a premium real estate developer launches Tycoons Square in Kalyan
DBS honoured as 'World's Best Bank' for fourth straight year
Marathon Group launches 5th project in budget homes series in Bhandup, with 5000+ more homes in the pipeline
Glenmark concludes post marketing surveillance (PMS) study on Favipiravir (FabiFluÂ®) in 1000+ COVID-19 patients, findings reinforce the drug's safety and efficacy in real world settings
Mega Champions Tournament worth Rs.11 Lakhs to begin on KhelPlay Rummy
Netcore Cloud's Smartech Automation Adopted by D2C Customized Health InsurTech Company, Vital
Tanishq Launches 'Stunning Every Ear'
Strengthening its commitment to connecting the futures of work and education, edtech startup Harappa announces Bridge Charter 2021: Five Resolutions Towards 2022 and Beyond
Adecco Group Completes Financing To Support Acquisition Of AKKA Technologies
Institute of Risk Management Declares Results for August 2021 Level-1 Examination in India
Tazapay Partners with B2B Marketplaces to Further Enable International Trade with Escrow Payments
Woolpert Acquires AAM, Global Geospatial Leader
STL appoints former Ericsson Executive Paolo Colella to its Advisory Council
EPEIOS 14-Liter 6-in-1 Air Fryer Oven Makes Cooking A Cinch
INFODAS SDoT Security Gateway receives EU SECRET approval enabling digitization of EU Classified Information systems
Casio to Release First G-SHOCK MUDMASTER Built with Forged Carbon
Casio to Release MT-G with All-New Exterior Design Featuring Multilayer Carbon Bezel
Introducing the Nobu App
Deltek Announces the 14th Annual Most Valuable Project Award Winners at Insight 2021
10,000 green hydrogen generators per month: groundbreaking for Enapter electrolyser mass production in North Rhine-Westphalia
Deltek Specpoint, The Next Generation Specification Solution, Launched at Deltek Insight 2021
2021 .ORG Impact Awards Finalists Named
Operational technology vulnerabilities increased by 46%, Skybox Security research reveals
Global Fab Equipment Spending Projected to Reach New High of Nearly $100 Billion in 2022, SEMI Reports
Free2Move Lauded by Frost & Sullivan as OEM New Mobility Marketplace Company of the Year
SC Johnson Invites Londoners to Walk Beneath the Ocean's Surface in The Blue Paradox - An Immersive Experience Exploring the Ocean Plastic Pollution Crisis
Supermicro Introduces Rack Plug and Play Cloud Infrastructure with Free Remote Access Testing and Validation
Point-of-Care Ultrasound World Conference - September 17-18, 2021 Hosted by the Point-of-Care Ultrasound Certification Academy
KPM Analytics Launches Automated SRC (Solvent Retention Capacity) Analyzer for the Baking and Milling Industries
Bringg Announces "Last Mile by Bringg on Salesforce" as part of Salesforce Fulfillment Network on Salesforce AppExchange, the World's Leading Enterprise Cloud Marketplace
PolyU develops groundbreaking and highly effective targeted osteoarthritis pain reliever
Simplilearn Launches Ambition #CannotBeLockedDown Campaign Inspiring Aspirants to Challenge All Odds
QuEST Global appoints Alfonso MartĂnez as Global Business Head for its Automotive and Rail Verticals
Brinton Pharmaceuticals launches a consumer brand 'HĂ¶hner Health' in India to focus on wellness and personal care category
Rising Data Creation and Consumption Fuel the Data Center Colocation Services Market Worldwide
FreightFox is the only Indian startup chosen in 100+ Accelerator Global program
Lowest Mileage Hemi Cuda Sells on Sonicbidder.com Ahead of Muscle Car Auction September 22, 2021
Parallel Wireless Expands Open RAN Research and Development Centers Across the Globe
Sense Demonstrates True Real-Time Residential Load Disaggregation and AI at The Future of Utilities Summit, Booth 14
New Research Reveals Top Residence-by-Investment Cities for Business
Renowned dental materials manufacturer Prevest DenPro Limited's IPO to open on BSE SME platform on 15th Sept
Purple Quarter Closes Sriram Sivarajan as the CTO for Maatrum Technologies
Eleva Reaches Industrial Production Scale and Prepares for Clinical Development of Factor H
Aviation Defence Universe (ADU Media) Helms Pristine and Savant Defence News Unabated
Fortune Education: MBBS Admission in Bangladesh for the academic year 2021-22; Registration & Seat Booking started in various colleges
Gates Foundation's Annual Goalkeepers Report Finds Stark Disparities in COVID-19 Impacts
Jemincare group has completed the Phase I clinical trial of its anti-SARS-CoV-2 neutralizing antibody JMB2002
Wyre to Enable Simple Payment Solutions and Accelerate DeFi Growth on Algorand
Aligning Advanced SPM Solutions with Business Objectives Creates High-performing Sales Teams
Belkin International Awarded Sustainability Leadership Award in 2021 Sustainability Awards
Mitsubishi Chemical Advanced Materials Announces Hiring of Global Director - Sustainable Solutions
Clarivate Announces Winner of Eugene Garfield Award 2021
The EdHeroes Movement is launched. Its aim: to address the most pressing challenges in education
Supermicro Expands Total Solution Portfolio by Offering Nutanix NX Platforms for Hybrid Multi-cloud Solutions
Skycatch Launches Proprietary 3D and 4D Software for the M300 at MINExpo, Delivering End to End Power and 24x Faster Data Processing at the Edge
SkyBridge and NAX Announces Groundbreaking Partnership to Accelerate the Growth of Decentralized Applications on Algorand
More than 150 thought leaders to join WRI India's Connect Karo 2021 virtually; will deliberate on building clean, green and just cities over a week-long discussion
Global safety brand KARAM introduces Kid's Masks
Workplace from Facebook Acclaimed by Frost & Sullivan for Elevating the Employee Experience with Its Organizational Communications Platform
Xinhua Silk Road: China-ASEAN Meteorological Development Index unveils 1st batch core results, further co-op achievements expected
5G Leadership Summit 2021 Concluded Successfully by Konnect Worldwide Business Media
RedHill Biopharma Accelerates Ongoing U.S. Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients with South African Approval
e-Money Announces Integration with the Algorand Blockchain to Accelerate the Circulation of European Stablecoins
Introducing the World's First Curated NFT Launchpad
DBS introduces real-time digital cross-border incoming payment tracking for all corporate and SME clients
Avia Solutions Group to enter into strategic partnership with Certares through a â‚¬300 million investment in the Group
HarperCollins presents 'The Bollywood Affair' by Gauri Sinh
Revised: J.P. Morgan opens new campus in Hyderabad
The Leela Palaces, Hotels and Resorts Voted as the World's Best Hotel Brand For The Second Consecutive Year By Travel + Leisure USA World's Best Awards 2021
Respiratory Health Management Market to Expedite Digital, Smart, and Portable Solutions
Study on Sputnik Light (first component of Sputnik V) vaccine's efficacy among the elderly in Argentina published in EClinicalMedicine journal
Forrester: 24% Of Indian Brands Delivered Poorer Customer Experiences In 2021
ISKENDERIAN Launches Jewels & Watches Online Auction
An innovative system based on optical fibers will monitor IEC's transmission lines for faults and damage
Leading Payments Technology Provider Opus Consulting Solutions Announces Hiring Spree In A Bid To Meet Growing Demand
SPJIMR recognised as a top global business school in 2021 FT rankings
Innova Medical Group Gifts ÂŁ10m To Launch Global Pandemic Institute In Liverpool
Outline for Building Chengdu into a World Famous City of Sports Events
CGTN: Xi Jinping: A role model in respecting teachers
Shoolini breaks into the top 100 universities league
Nina Kraviz kicked-off the Formula 1 Heineken Gran Premio d'Italia 2021 weekend in style with a headline performance at the HeinekenÂ® Greener Bar in Milan